U130医药(L11205)
动态评分: 0.00分
业绩表现
| 总收益 | 年化收益 | 标准差 | 夏普比率 | 最大回撤 | 最大收益 | |
| 成立以来 | 121.95% | 8.47% | 9.92% | 25.73% | -78.01% | 414.58% |
| 过去1年 | 70.51% | 10.24% | 162.92% | -20.94% | 133.51% | |
| 过去2年 | 53.77% | 24.01% | 12.2% | -2.09% | -45.8% | 179.35% |
| 过去3年 | 51.18% | 14.77% | 13.06% | 22.76% | -59.65% | 179.35% |
| 过去5年 | -23.88% | -5.31% | 11.84% | -27.09% | -78.01% | 179.35% |
